Beriberi
ICD-10 E51.1 is a billable code used to indicate a diagnosis of beriberi.
Beriberi is a disease caused by a deficiency of thiamine (vitamin B1), which is essential for carbohydrate metabolism and nerve function. The condition can manifest in two primary forms: wet beriberi, which affects the cardiovascular system, leading to symptoms such as edema, heart failure, and increased heart rate; and dry beriberi, which primarily impacts the nervous system, resulting in peripheral neuropathy, muscle weakness, and ataxia. Beriberi is often seen in populations with a high intake of polished rice, which lacks thiamine, and in individuals with malabsorption syndromes, chronic alcoholism, or those on parenteral nutrition without adequate vitamin supplementation. Diagnosis is typically based on clinical presentation and dietary history, and treatment involves thiamine supplementation and dietary modifications to include thiamine-rich foods such as whole grains, legumes, nuts, and seeds. Early recognition and intervention are crucial to prevent irreversible neurological damage.
Detailed dietary assessments and history of vitamin intake.
Patients with malnutrition, chronic alcoholism, or gastrointestinal disorders.
Ensure documentation reflects the patient's dietary habits and any supplementation provided.
Neurological assessments and symptom descriptions.
Patients presenting with neuropathy or cognitive changes.
Document neurological findings thoroughly to support the diagnosis.
Used for follow-up visits for patients diagnosed with beriberi.
Document the patient's symptoms, dietary history, and treatment plan.
Nutrition specialists should include dietary assessments.
Symptoms of beriberi can vary based on the type. Wet beriberi typically presents with cardiovascular symptoms such as edema and heart failure, while dry beriberi presents with neurological symptoms like peripheral neuropathy and muscle weakness.
Treatment for beriberi involves thiamine supplementation and dietary changes to include thiamine-rich foods. In severe cases, hospitalization may be required for intravenous thiamine administration.
